We are analyzing https://link.springer.com/article/10.1007/s00262-011-1047-x.

Title:
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release | Cancer Immunology, Immunotherapy
Description:
Damage-associated molecular patterns (DAMPs), danger signal molecules expressed after injury or infection, have become recognized as prerequisite for orchestrating effective anti-tumor host response. The expression of two prototypical DAMPs, calreticulin and high-mobility group box-1 (HMGB1) protein, was examined following Photofrin™-photodynamic therapy (PDT) of Lewis lung carcinoma (LLC) cells in vitro and LLC tumors growing in syngeneic mice. Cell surface expression of calreticulin was found to be highly increased at 1 h after PDT treatment both in vitro and in vivo. Increased exposure of calreticulin was also detected on the surface of macrophages from PDT-treated LLC tumors. At the same time interval, a rise in serum HMGB1 was detected in host mice. Intracellular staining of macrophages co-incubated for 16 h with PDT-treated LLC cells revealed elevated levels of HMGB1 in these cells. The knowledge of the involvement of these DAMPs uncovers important mechanistic insights into the development of host response induced by PDT.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, google, scholar, cas, pubmed, cancer, calreticulin, cell, therapy, cells, photodynamic, korbelik, hmgb, response, expression, group, box, release, biol, zhang, damps, host, access, death, privacy, cookies, content, highmobility, immunity, immunol, activation, publish, research, search, damageassociated, molecular, patterns, tumor, surface, danger, llc, vivo, apoptosis, nat, data, information, log, journal, involvement, mladen,

Topics {✒️}

high-mobility group box-1 month download article/chapter lewis lung carcinoma wei zhang & soroush merchant hmgb1/dna immune complexes pdt-treated llc tumors photodynamic therapy-generated vaccines nk/idc interaction results host response induced article cancer immunology photofrin-based photodynamic therapy related subjects full article pdf cell-mediated immunity endoplasmic reticulum stress anti-tumor immunity privacy choices/manage cookies provided photofrin™ host cell populations murine sccvii tumor llc tumors growing dougherty gj polypeptide binding conformation photofrin™-photodynamic therapy clinical photodynamic therapy immunogenic cell death cell death differ european economic area rock kl oxidation-specific epitopes tetrasulfonated aluminium phthalocyanine murphy-ullrich je rage-independent autoreactive cancer cell death nk cell activation article korbelik er chaperone calreticulin chromatin protein hgmb1 check access instant access dying cells alert immune cell infiltration cell surface expression cell-surface expression article log tumor response accepting optional cookies surface-exposed calreticulin pattern recognition receptors macrophage cytokine release

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
         description:Damage-associated molecular patterns (DAMPs), danger signal molecules expressed after injury or infection, have become recognized as prerequisite for orchestrating effective anti-tumor host response. The expression of two prototypical DAMPs, calreticulin and high-mobility group box-1 (HMGB1) protein, was examined following Photofrin™-photodynamic therapy (PDT) of Lewis lung carcinoma (LLC) cells in vitro and LLC tumors growing in syngeneic mice. Cell surface expression of calreticulin was found to be highly increased at 1 h after PDT treatment both in vitro and in vivo. Increased exposure of calreticulin was also detected on the surface of macrophages from PDT-treated LLC tumors. At the same time interval, a rise in serum HMGB1 was detected in host mice. Intracellular staining of macrophages co-incubated for 16 h with PDT-treated LLC cells revealed elevated levels of HMGB1 in these cells. The knowledge of the involvement of these DAMPs uncovers important mechanistic insights into the development of host response induced by PDT.
         datePublished:2011-06-05T00:00:00Z
         dateModified:2011-06-05T00:00:00Z
         pageStart:1431
         pageEnd:1437
         sameAs:https://doi.org/10.1007/s00262-011-1047-x
         keywords:
            Calreticulin
            DAMPs
            HMGB1
            Lewis lung carcinoma
            Photodynamic therapy
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig4_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:60
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mladen Korbelik
               affiliation:
                     name:British Columbia Cancer Agency
                     address:
                        name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Wei Zhang
               affiliation:
                     name:British Columbia Cancer Agency
                     address:
                        name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Soroush Merchant
               affiliation:
                     name:British Columbia Cancer Agency
                     address:
                        name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
      description:Damage-associated molecular patterns (DAMPs), danger signal molecules expressed after injury or infection, have become recognized as prerequisite for orchestrating effective anti-tumor host response. The expression of two prototypical DAMPs, calreticulin and high-mobility group box-1 (HMGB1) protein, was examined following Photofrin™-photodynamic therapy (PDT) of Lewis lung carcinoma (LLC) cells in vitro and LLC tumors growing in syngeneic mice. Cell surface expression of calreticulin was found to be highly increased at 1 h after PDT treatment both in vitro and in vivo. Increased exposure of calreticulin was also detected on the surface of macrophages from PDT-treated LLC tumors. At the same time interval, a rise in serum HMGB1 was detected in host mice. Intracellular staining of macrophages co-incubated for 16 h with PDT-treated LLC cells revealed elevated levels of HMGB1 in these cells. The knowledge of the involvement of these DAMPs uncovers important mechanistic insights into the development of host response induced by PDT.
      datePublished:2011-06-05T00:00:00Z
      dateModified:2011-06-05T00:00:00Z
      pageStart:1431
      pageEnd:1437
      sameAs:https://doi.org/10.1007/s00262-011-1047-x
      keywords:
         Calreticulin
         DAMPs
         HMGB1
         Lewis lung carcinoma
         Photodynamic therapy
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1047-x/MediaObjects/262_2011_1047_Fig4_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:60
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mladen Korbelik
            affiliation:
                  name:British Columbia Cancer Agency
                  address:
                     name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Wei Zhang
            affiliation:
                  name:British Columbia Cancer Agency
                  address:
                     name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Soroush Merchant
            affiliation:
                  name:British Columbia Cancer Agency
                  address:
                     name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:60
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:British Columbia Cancer Agency
      address:
         name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
         type:PostalAddress
      name:British Columbia Cancer Agency
      address:
         name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
         type:PostalAddress
      name:British Columbia Cancer Agency
      address:
         name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mladen Korbelik
      affiliation:
            name:British Columbia Cancer Agency
            address:
               name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Wei Zhang
      affiliation:
            name:British Columbia Cancer Agency
            address:
               name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:Soroush Merchant
      affiliation:
            name:British Columbia Cancer Agency
            address:
               name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
               type:PostalAddress
            type:Organization
PostalAddress:
      name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
      name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
      name:British Columbia Cancer Research Centre, British Columbia Cancer Agency, Vancouver, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(135)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.27s.

LINK . SPRINGER . COM {}